BDTX-507

N/A

Report date: 2023/05/22 10:20:10
NME

Base Information

Drug NameBDTX-507
Drug Alias NameBDTX-507
ClassificationSmall molecules
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBlack Diamond Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBlack Diamond Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A